KALA – kala bio, inc. (US:NASDAQ)

News

KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
KALA BIO (NASDAQ:KALA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com